XRP Falls 10% In Bearish Trade

- XRP was trading at $2.1385 by 04:55 (09:55 GMT) on the Index on Friday, down 10.31% on the day. It was the largest one-day percentage loss since...

Read More
Investors hope for 'Santa Claus' rally as stocks lose steam

The benchmark S&P 500 is up more than 23% for 2024, even after a major stumble this week, and Wall Street has historically often enjoyed a strong annual close. Since 1969, the last five trading days of the year combined with the first two of the following year have yielded an average S&P 500 gain of 1.3%, a period known as the "Santa Claus Rally," according to the Stock Trader's Almanac. But this year, there are signs Santa Claus may disappoint.

Read More
US election outcome won’t slow Q4 Bitcoin rally, says hedge fund

Bitcoin’s price will benefit from the upcoming United States presidential election regardless of who wins, …

Read More
Hedge-fund strategist flags biggest concern for markets in 2025 — and offers ideas for taking shelter

Ed Cole, head of multi strategy, equities at Man Group talks inflation risks and the problem with investors all in on the U.S. market.

Read More
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms

Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down double digits in premarket trading.

Read More
Analysts sound alarms on Palantir stock into 2025

Here's what could happen to Palantir's shares next.

Read More
Ignore New York At Your Peril: NYC Office Market Hits Overdrive, Breathing Life Into The City's Business And Real Estate

Comedian Jerry Seinfeld is having the last laugh. New York is back in business. During the pandemic, when The New York Times published an article questioning if New York was over, Seinfeld hit back at the hand-wringing skeptics with a Times article of his own, “So You Think New York Is ‘Dead’ (It’s not).” He was right. Recent numbers show that the Big Apple’s commercial real estate numbers are back to pre-pandemic levels as workers return to the office en masse, breathing life into surrounding b

Read More
BlackRock to Launch Nasdaq-100 Ex-Top 30 ETF in Europe

The new fund follows the launch of BlackRock's S&P 500 top-20 ETF.

Read More
Trump Media stock slumps 4% after Donald Trump moved all his DJT shares to a trust

Shares of Trump Media & Technology Group (DJT) slipped almost 4% in pre-market trading Friday, after regulatory filings showed President-elect Donald Trump moved the entirety of his stake in the company to a revocable trust.

Read More
Fed's Preferred Inflation Gauge Falls More Than Expected: Markets Breathe Sigh Of Relief

The Federal Reserve’s key inflation measure came in below expectations for November, delivering welcome relief Friday to markets after the central bank warned earlier this week of mounting price pressures heading into the new year. The Personal Consumption Expenditures price index grew by 2.4% in November 2024 on a year-over-year basis, up from 2.3% in October, according to government data. The figure missed economist forecasts of 2.5%, yet it marked the second consecutive monthly increase in th

Read More
Why Trump’s bull stampede in markets is just starting: Former TD Ameritrade CEO

Former TD Ameritrade CEO Joe Moglia stops by to share why investors have plenty to be excited about regarding Trump 2.0 markets.

Read More
Winnebago Industries Stock Falls After Q1 Earnings Miss Amid Challenging Marine Operating Environment

Winnebago Industries, Inc. (NYSE:WGO) shares are trading lower in the premarket session on Friday. The company reported first-quarter adjusted loss per share of 3 cents, missing the analyst consensus estimate for EPS of 20 cents. Quarterly sales were $625.60 million (down 18%), which was missing the analyst consensus estimate of $672.232 million. Revenues fell amid lower unit volume and a reduced average selling price per unit related to product mix. Gross profit was $76.8 million, a decrease of

Read More
Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday?

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss and when autologous vein graft is not feasible. Symvess, or the ATEV, is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for arterial replacement and repair. Also Read: Delay Hits Humac

Read More
US-Listed Chinese Stocks Fall As China's Central Bank Keeps Key Rates Steady

On Friday, China’s central bank, the People’s Bank of China (PBOC), decided to maintain its main benchmark lending rates amid efforts to support economic growth while managing a weakening yuan. The one-year loan prime rate (LPR) remains at 3.1%, while the five-year LPR is steady at 3.6%, influencing corporate loans, household lending, and mortgages. This decision aligned with expectations from a Reuters poll of 27 economists, CNBC reports. Also Read: Amazon’s Project Kuiper In Talks With Taiwan

Read More

OK